SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-07-000641
Filing Date
2007-08-07
Accepted
2007-08-07 16:45:10
Documents
6
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a32629e10vq.htm 10-Q 155716
2 EXHIBIT 10.1 a32629exv10w1.htm EX-10.1 20724
3 EXHIBIT 10.2 a32629exv10w2.htm EX-10.2 6443
4 EXHIBIT 31.1 a32629exv31w1.htm EX-31.1 8489
5 EXHIBIT 31.2 a32629exv31w2.htm EX-31.2 8464
6 EXHIBIT 32.1 a32629exv32w1.htm EX-32.1 5941
  Complete submission text file 0000936392-07-000641.txt   207184
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 071032154
SIC: 2836 Biological Products, (No Diagnostic Substances)